Statins and hepatotoxicity: Focus on patients with fatty liver

被引：205
作者：
Chalasani, N [1 ]
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN 46202 USA
来源：
HEPATOLOGY | 2005年 / 41卷 / 04期
关键词：
D O I：
10.1002/hep.20671
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：690 / 695
页数：6
相关论文
共 49 条
[1]   Use and monitoring of "statin" lipid-lowering drugs compared with guidelines [J].
Abookire, SA ;
Karson, AS ;
Fiskio, J ;
Bates, DW .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (01) :53-58
[2]   Fatty infiltration of liver in hyperlipidemic patients [J].
Assy, N ;
Kaita, K ;
Mymin, D ;
Levy, C ;
Rosser, B ;
Minuk, G .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (10) :1929-1934
[3]   Safety of statins - Focus on clinical pharmacokinetics and drug interactions [J].
Bellosta, S ;
Paoletti, R ;
Corsini, A .
CIRCULATION, 2004, 109 (23) :50-57
[4]   Do statins cause cancer? A meta-analysis of large randomized clinical trials [J].
Bjerre, LM ;
LeLorier, J .
AMERICAN JOURNAL OF MEDICINE, 2001, 110 (09) :716-723
[5]   Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors -: The role of metabolism -: Monograph for physicians [J].
Bottorff, M .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (15) :2273-2280
[6]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[7]  
Burdick L, 2004, HEPATOLOGY, V40, p589A
[8]   The liver and statin drug therapy: uncertain navigation in the sea of risk-benefit [J].
Caldwell, SH ;
Zaidman, JS ;
Hespenheide, EE .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (04) :303-306
[9]   Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis [J].
Chalasani, N ;
Deeg, MA ;
Crabb, DW .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (08) :1497-1502
[10]   Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity [J].
Chalasani, N ;
Aljadhey, H ;
Kesterson, J ;
Murray, MD ;
Hall, SD .
GASTROENTEROLOGY, 2004, 126 (05) :1287-1292
12345